![Safi R. Bahcall](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Safi R. Bahcall
Nessuna posizione attualmente
Profilo
Safi R.
Bahcall was the founder who had held the position of President, Chief Executive Officer & Director at Synta Pharmaceuticals Corp.
from 2010 to 2014.
He founded Synta Pharmaceuticals Corp.
in 2000.
Dr. Bahcall has an undergraduate degree from Harvard University and a doctorate degree from Stanford University.
Precedenti posizioni note di Safi R. Bahcall
Società | Posizione | Fine |
---|---|---|
Synta Pharmaceuticals Corp.
![]() Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Fondatore | 03/03/2014 |
Formazione di Safi R. Bahcall
Harvard University | Undergraduate Degree |
Stanford University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Synta Pharmaceuticals Corp.
![]() Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |
- Borsa valori
- Insiders
- Safi R. Bahcall